These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15997503)

  • 1. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 2. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio-guided surgery for non-131I-avid thyroid cancer.
    Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
    Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
    Blount CL; Dworkin HJ
    Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma.
    Boz A; Arici C; Güngör F; Yildiz A; Colak T; Karayalçin B
    Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results.
    Rubello D; Piotto A; Pagetta C; Pelizzo MR; Casara D
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1201-5. PubMed ID: 12192566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
    Curtet C; Carlier T; Mirallié E; Bodet-Milin C; Rousseau C; Barbet J; Kraeber-Bodéré F
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1556-62. PubMed ID: 17522858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
    Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
    J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
    Leboeuf R; Bénard F; Langlois MF
    Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
    Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
    Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
    Tuncel M; Ozgen Kiratli P
    Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.